Electronics & Pharma Secure 70% of FY25 PLI Funds: Govt Data
The Production Linked Incentive (PLI) scheme, launched in 2021 to boost domestic manufacturing, has been instrumental in driving growth and investment in India’s economy. The scheme, which was initially rolled out for 14 key sectors, has been a significant success, with the electronics and pharma sectors emerging as the top beneficiaries.
According to official data, the electronics and pharma sectors received nearly 70% of the ₹10,114 crore disbursed under the PLI scheme in FY25. The electronics sector got ₹5,732 crore, while pharma received ₹2,328 crore, making them the top beneficiaries.
The PLI scheme is a key initiative of the government to promote domestic manufacturing and reduce dependence on imports. The scheme offers a financial incentive to companies that invest in producing high-value products in India, incentivizing them to set up manufacturing units in the country.
The data highlights the significance of the electronics and pharma sectors in India’s economy. The electronics sector has been a key driver of growth in recent years, with the country emerging as a major hub for electronics manufacturing in Asia. The sector has received significant investments from global companies, including Samsung, Apple, and Foxconn.
The pharma sector, on the other hand, has been a key player in India’s healthcare industry. The country is one of the largest producers of generic medicines in the world, with many global pharmaceutical companies having set up manufacturing units in India. The sector has received significant investments from companies such as Pfizer, Merck, and Novartis.
The PLI scheme has been instrumental in driving growth in these sectors. The scheme offers a financial incentive to companies that invest in producing high-value products in India, incentivizing them to set up manufacturing units in the country. The scheme has been designed to promote domestic manufacturing, reduce dependence on imports, and increase exports.
The PLI scheme has been a significant success, with many companies having set up manufacturing units in India under the scheme. The scheme has also led to an increase in foreign direct investment (FDI) in India, with many global companies having invested in the country.
The success of the PLI scheme is also reflected in the growth of India’s exports. India’s exports have been growing rapidly in recent years, with the country emerging as a major player in global trade. The PLI scheme has been instrumental in driving growth in India’s exports, with many companies having set up manufacturing units in India to export their products globally.
The PLI scheme has also led to an increase in employment in India. The scheme has created thousands of jobs in the manufacturing sector, providing employment opportunities to millions of people. The scheme has also led to an increase in income levels in rural areas, as many companies have set up manufacturing units in rural areas, creating jobs and stimulating local economies.
The success of the PLI scheme is a testament to the government’s commitment to promoting domestic manufacturing and reducing dependence on imports. The scheme has been instrumental in driving growth and investment in India’s economy, and it is expected to continue to play a key role in the country’s economic development in the coming years.
In conclusion, the electronics and pharma sectors have been the top beneficiaries of the PLI scheme in FY25, receiving nearly 70% of the total funds disbursed under the scheme. The scheme has been a significant success, driving growth and investment in India’s economy, and it is expected to continue to play a key role in the country’s economic development in the coming years.
